StockData
Cytosorbents Corp logo

Cytosorbents Corp (CTSO) stock

CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 2/30
$5.57+1.05 (+23.12%)

Close on Nov 18, 2026Market cap $349.72MP/E –Yield –

Cytosorbents net income

Net income is the profit left for shareholders after every expense, interest and tax.

Cytosorbents's net income for the twelve months ending Jun 30, 2026 was -$18.21M. For fiscal 2025 it was -$8.20M. The highest annual figure on record is -$1.10M in fiscal 2004.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$8.20M–
FY2024Dec 31, 2024-$20.72M–
FY2023Dec 31, 2023-$29.25M–
FY2022Dec 31, 2022-$32.81M–
FY2021Dec 31, 2021-$24.56M–
FY2020Dec 31, 2020-$7.84M–
FY2019Dec 31, 2019-$19.27M–
FY2018Dec 31, 2018-$17.21M–
FY2017Dec 31, 2017-$8.46M–
FY2016Dec 31, 2016-$11.76M–
FY2015Dec 31, 2015-$9.48M–
FY2014Dec 31, 2014-$9.32M–
FY2013Dec 31, 2013-$4.68M–
FY2012Dec 31, 2012-$3.66M–
FY2011Dec 31, 2011-$5.48M–
FY2010Dec 31, 2010-$2.91M–
FY2009Dec 31, 2009-$2.74M–
FY2008Dec 31, 2008-$3.02M–
FY2007Dec 31, 2007-$3.35M–
FY2006Dec 31, 2006-$76.72M–
FY2005Dec 31, 2005-$3.67M–
FY2004Dec 31, 2004-$1.10M–
FY2003Dec 31, 2003-$6.01M–
FY2002Dec 31, 2002-$11.87M–
FY2001Dec 31, 2001-$15.39M–
FY2000Dec 31, 2000-$3.07M–
FY1999Dec 31, 1999-$10.75M–
FY1998Dec 31, 1998-$1.87M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.42M-326.9%
Q1 FY2026Mar 31, 2026-$5.13M–
Q4 FY2025Dec 31, 2025-$5.50M–
Q3 FY2025Sep 30, 2025-$3.17M–
Q2 FY2025Jun 30, 2025$1.95M–
Q1 FY2025Mar 31, 2025-$1.48M–
Q4 FY2024Dec 31, 2024-$7.57M–
Q3 FY2024Sep 30, 2024-$2.77M–
Q2 FY2024Jun 30, 2024-$4.29M–
Q1 FY2024Mar 31, 2024-$6.09M–
Q4 FY2023Dec 31, 2023-$6.57M–
Q3 FY2023Sep 30, 2023-$9.19M–
Q2 FY2023Jun 30, 2023-$6.15M–
Q1 FY2023Mar 31, 2023-$7.33M–
Q4 FY2022Dec 31, 2022-$766.13K–
Q3 FY2022Sep 30, 2022-$12.20M–
Q2 FY2022Jun 30, 2022-$10.88M–
Q1 FY2022Mar 31, 2022-$8.97M–
Q4 FY2021Dec 31, 2021-$9.31M–
Q3 FY2021Sep 30, 2021-$6.41M–
Q2 FY2021Jun 30, 2021-$4.68M–
Q1 FY2021Mar 31, 2021-$4.17M–
Q4 FY2020Dec 31, 2020-$677.72K–
Q3 FY2020Sep 30, 2020-$839.73K–
Q2 FY2020Jun 30, 2020-$2.87M–
Q1 FY2020Mar 31, 2020-$3.45M–
Q4 FY2019Dec 31, 2019-$3.95M–
Q3 FY2019Sep 30, 2019-$6.89M–
Q2 FY2019Jun 30, 2019-$3.55M–
Q1 FY2019Mar 31, 2019-$4.88M–
Q4 FY2018Dec 31, 2018-$5.40M–
Q3 FY2018Sep 30, 2018-$3.00M–
Q2 FY2018Jun 30, 2018-$5.82M–
Q1 FY2018Mar 31, 2018-$2.98M–
Q4 FY2017Dec 31, 2017-$3.15M–
Q3 FY2017Sep 30, 2017-$2.05M–
Q2 FY2017Jun 30, 2017-$1.73M–
Q1 FY2017Mar 31, 2017-$1.52M–
Q4 FY2016Dec 31, 2016-$4.91M–
Q3 FY2016Sep 30, 2016-$2.19M–

More Cytosorbents figures

See a number that looks wrong?